7204US Cardiolipin-GM (FDA cleared)
Intended Use:
AESKULISA Cardiolipin-GM is a solid phase enzyme immunoassay for the quantitative and qualitative detection of IgG and /or IgM antibodies against cardiolipin in human serum.
Recombinant Antigens:
n.a.
Native Antigens:
ß2-Glycoprotein I, Cardiolipin
Published in
Thrombosis (FDA cleared Products)
Tagged under